SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON 26 JUNE 2024 AT 1330 AT SHANGHAI TIANHYJIA FUTUK HOTEL, 358 HONGXU ROAD, SHANGHAI, CHINA, AND A CLASS H SHAREHOLDER MEETING WILL BE HELD ON THE SAME DAY FOLLOWING THE END OF THE ANNUAL GENERAL MEETING AND THE CLASS A SHAREHOLDER MEETING. The meeting will include Annual Report, Board and Board Work Report, Financial Decision Report, Profit Distribution Projections, Audit Agency Appointment, Director Review Results and Remuneration, Appointment of Loans/Borrowings, Total Grant Requests, Disposal of Listed Company Shares, Issuance of Debt Financing Instruments, Revised Fundraising Proposed financial management and related transaction management system, provision of loans to joint ventures, extension and addition of guarantees, grant general authorization to issue A...Show More

SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON 26 JUNE 2024 AT 1330 AT SHANGHAI TIANHYJIA FUTUK HOTEL, 358 HONGXU ROAD, SHANGHAI, CHINA, AND A CLASS H SHAREHOLDER MEETING WILL BE HELD ON THE SAME DAY FOLLOWING THE END OF THE ANNUAL GENERAL MEETING AND THE CLASS A SHAREHOLDER MEETING. The meeting will include Annual Report, Board and Board Work Report, Financial Decision Report, Profit Distribution Projections, Audit Agency Appointment, Director Review Results and Remuneration, Appointment of Loans/Borrowings, Total Grant Requests, Disposal of Listed Company Shares, Issuance of Debt Financing Instruments, Revised Fundraising Proposed financial management and related transaction management system, provision of loans to joint ventures, extension and addition of guarantees, grant general authorization to issue A shares and/or H shares, grant general authorization to repurchase H shares and A shares, and amend the Articles of Association and their annexes. The relevant notice and proxy forms are published on the Company's website and the Shanghai Stock Exchange website and the website of the Shanghai Stock Exchange are responsible for round-trip and lodging expenses incurred by shareholders or their representatives.